PATENT CLAIM ANALYSIS

Application Number: 15873540
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-11
Patent Classification: ["514", "647000"]

Abstract:
Treatment of CNS disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine; and (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine is disclosed. A process for preparing 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine is also disclosed. The process includes the preparation of all four isomers of N-[4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]formamide, which are also useful.

Claim (Index 4):
A method according to  claim 1 , wherein the compound of formula PQ is (1R,4S)\u2014N-[4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine or a salt thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.69231
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15299186', '14727260', '12847270', '12173626', '13365565']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8039750328677527
- 35 USC 102 Novelty (BERT): 0.5724455455155691
- Combined Prediction Score: 0.7808220841325344
- Mean Citation Score: 421.050712
- Max Citation Score: 434.93433
- Similarity Product: 433.3483709525389

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test